Related references
Note: Only part of the references are listed.Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3
Hiroko Toda et al.
JOURNAL OF HUMAN GENETICS (2018)
Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma
Qiang Su et al.
JOURNAL OF CANCER (2018)
miR-221/222 activate the Wnt/beta-catenin signaling to promote triple-negative breast cancer
Sanhong Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2018)
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy
Elnaz Pashaei et al.
PLOS ONE (2017)
Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
Hye-Lim Ju et al.
CHINESE JOURNAL OF CANCER RESEARCH (2016)
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma
Anne Caudron et al.
EXPERIMENTAL DERMATOLOGY (2016)
Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
Magdalena L. Plasilova et al.
MEDICINE (2016)
CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells
Lijuan Xiong et al.
ONCOTARGET (2016)
Concepts and targets in triple-negative breast cancer: recent results and clinical implications
Poornima Saha et al.
Therapeutic Advances in Medical Oncology (2016)
CD 147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis
Hongkai Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells
Patsy S. H. Soon et al.
ENDOCRINE-RELATED CANCER (2013)
CD147 in Ovarian and Other Cancers
Hong Yang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness
G. Daniel Grass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
CD147, MMP9 expression and clinical significance of basal-like breast cancer
Ying Liu et al.
MEDICAL ONCOLOGY (2013)
Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma
Qiang Lu et al.
ONCOLOGY LETTERS (2013)
EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
Geraldine Lescaille et al.
BMC CANCER (2012)
Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer
Qiu-Wan Wu et al.
BMC CANCER (2012)
Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy
Hiroshi Yagata et al.
BREAST CANCER (2011)
Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma
Fangfang Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
CD147 expression in pituitary adenomas and its significance for clinical outcome
Xin Qu et al.
HUMAN PATHOLOGY (2010)
New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites
Inhan Lee et al.
GENOME RESEARCH (2009)
HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection
Yu Li et al.
HISTOPATHOLOGY (2009)
Up-regulation of CD147 and matrix metalloproteinase-2,-9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells
Qing-Quan Li et al.
CANCER SCIENCE (2007)
MicroRNA expression detected by oligonucleotide microarrays: System establishment and expression profiling in human tissues
O Barad et al.
GENOME RESEARCH (2004)
Computational identification of Drosophila microRNA genes
EC Lai et al.
GENOME BIOLOGY (2003)
Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-C expression
K Imanaka-Yoshida et al.
VIRCHOWS ARCHIV (2001)
Tumorigenic potential of extracellular matrix metalloproteinase inducer
S Zucker et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
